Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus

被引：0
|
作者：
Christophe Bardin
Estelle Nobecourt
Etienne Larger
François Chast
Jean-Marc Treluyer
Saik Urien
机构：
[1] Hôtel-Dieu,Pharmacy
[2] AP-HP,Pharmacology
[3] Hôtel-Dieu,Toxicology Department
[4] AP-HP,Diabetology Department
[5] CIC-0901 Inserm Necker-Cochin,undefined
[6] AP-HP,undefined
[7] EA-3620,undefined
[8] Université Paris Descartes,undefined
来源：
European Journal of Clinical Pharmacology | 2012年 / 68卷
关键词：
Metformin; Population pharmacokinetics; Obese patient; Size descriptors; Diabetology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：961 / 968
页数：7
相关论文
共 50 条
  • [21] Rosiglitazone is effective in both obese and non-obese patients with type 2 diabetes.
    Cranmer, H
    Jones, NP
    Patwardhan, R
    DIABETOLOGIA, 1999, 42 : A228 - A228
  • [22] Serum fetuin-A levels in obese and non-obese subjects with and without type 2 diabetes mellitus
    Zhou, Zhong-wei
    Ju, Hui-xiang
    Sun, Ming-zhong
    Chen, Hong-mei
    Fu, Qing-ping
    Jiang, Dong-mei
    CLINICA CHIMICA ACTA, 2018, 476 : 98 - 102
  • [23] Differences in Emotional Distress among Inpatients with Type 1, Obese Type 2, and Non-Obese Type 2 Diabetes Mellitus
    Miyawaki, Yoshiko
    Iwahashi, Hiromi
    Okauchi, Yukiyoshi
    Sudo, Yoshiko
    Fujiwara, Yuko
    Omote, Yayoko
    Imagawa, Akihisa
    Shimomura, Iichiro
    INTERNAL MEDICINE, 2015, 54 (20) : 2561 - 2567
  • [24] Cholesterol metabolism in obese and non-obese subjects with type 2 diabetes
    Simonen, PP
    Gylling, HK
    Miettinen, TA
    CIRCULATION, 2000, 102 (18) : 283 - 283
  • [25] Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus A population-based study
    Liu, Wei
    Zhou, Xianghai
    Li, Yufeng
    Zhang, Simin
    Cai, Xiaoling
    Zhang, Rui
    Gong, Siqian
    Han, Xueyao
    Ji, Linong
    MEDICINE, 2020, 99 (06)
  • [26] C-reactive protein as an inflammatory marker in obese and non-obese type 2 diabetes mellitus patients with metabolic syndrome
    Siddiqui, Rabia
    Rukhsana, Nighat
    Jafri, Muhammad Sajid Abbas
    Shakoor, Shazia
    Iqbal, Samreen
    Younas, Muhammad
    RAWAL MEDICAL JOURNAL, 2024, 49 (04):
  • [27] Glimepiride pharmacokinetics in obese versus non-obese diabetic patients
    Shukla, UA
    Chi, EM
    Lehr, KH
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (01) : 30 - 35
  • [28] Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers
    Chairat, Kalayanee
    Jittamala, Podjanee
    Hanpithakpong, Warunee
    Day, Nicholas P. J.
    White, Nicholas J.
    Pukrittayakamee, Sasithon
    Tarning, Joel
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (06) : 1103 - 1112
  • [29] Population Pharmacokinetics of Metformin in Mexican Patients with Type 2 Diabetes Mellitus
    Barranco Garduno, L. M.
    Neri Salvador, J. C.
    Juarez Olguin, H.
    Lugo Goytia, G.
    Carrasco Portugal, M.
    Flores Murrieta, F.
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2015, 11 (06) : 632 - 637
  • [30] Leptin levels in non-obese and obese children and young adults with type 1 diabetes mellitus
    Verrotti, A
    Basciani, F
    Morgese, G
    Chiarelli, F
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (01) : 49 - 53
12345